KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) EBITDA: 2020-2025

Historic EBITDA for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$80.4 million.

  • Ginkgo Bioworks Holdings' EBITDA fell 47.77% to -$80.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$337.8 million, marking a year-over-year increase of 47.87%. This contributed to the annual value of -$550.3 million for FY2024, which is 38.08% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' EBITDA stood at -$80.4 million, which was down 39.13% from -$57.8 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' EBITDA peaked at -$26.7 million during Q3 2021, and registered a low of -$1.7 billion during Q4 2021.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median EBITDA value was -$168.9 million (recorded in 2024), while the average stood at -$151.6 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' EBITDA plummeted by 2,914.48% in 2021 and then surged by 90.04% in 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' EBITDA (Quarterly) stood at -$1.7 billion in 2021, then skyrocketed by 90.04% to -$167.8 million in 2022, then dropped by 23.55% to -$207.3 million in 2023, then soared by 47.13% to -$109.6 million in 2024, then crashed by 47.77% to -$80.4 million in 2025.
  • Its EBITDA was -$80.4 million in Q3 2025, compared to -$57.8 million in Q2 2025 and -$90.0 million in Q1 2025.